1.
Shojaeefar E, Ghaffari M, Mohammadi M, Hosseini J, Omrani MD. What we Know so far about Myxovirus Resistance Protein A (MxA) as a Biomarker of Interferon-Beta Therapy in Patients with Multiple Sclerosis: a Systematic Review. Arch Men Health [Internet]. 2020 Dec. 5 [cited 2025 Jul. 14];3(1):e19. Available from: https://journals.sbmu.ac.ir/index.php/amh/article/view/33124